Literature DB >> 22775476

History of non-fatal cardiovascular disease in a cohort of Dutch and British patients with haemophilia.

Dietje E Fransen van de Putte1, Kathelijn Fischer, Michael Makris, R Campbell Tait, Pratima Chowdary, Peter W Collins, Karina Meijer, Goris Roosendaal, Roger E G Schutgens, Eveline P Mauser-Bunschoten.   

Abstract

OBJECTIVE: Cardiovascular disease (CVD) mortality is reported to be lower in haemophilia patients than in the general population, but information on the occurrence of non-fatal CVD is lacking. The aim of our study was to assess CVD history in a cohort of living haemophilia patients.
METHODS: Retrospective data on the occurrence of myocardial infarction, angina pectoris, ischaemic stroke and intracranial bleeding in 709 living Dutch and British haemophilia patients aged 30 yr or older were analysed and compared with the general age-matched male population.
RESULTS: There was a trend towards a lower cumulative incidence of myocardial infarction (1.7% vs. 4.0%) and ischaemic stroke (0% vs. 1.5%) in patients with severe haemophilia than in the general population, while the occurrence of angina pectoris was similar (3.2 vs. 3.7%). As expected, the cumulative incidence of intracranial bleeding was, on the other hand, significantly increased in haemophilia patients (1.6% vs. 0.4% in the general population).
CONCLUSION: Our results suggest a protective effect of severe haemophilia against acute ischaemic CVD.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22775476     DOI: 10.1111/j.1600-0609.2012.01835.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  4 in total

1.  A cross-sectional analysis of cardiovascular disease in the hemophilia population.

Authors:  Suman L Sood; Dunlei Cheng; Margaret Ragni; Craig M Kessler; Doris Quon; Amy D Shapiro; Nigel S Key; Marilyn J Manco-Johnson; Adam Cuker; Christine Kempton; Tzu-Fei Wang; M Elaine Eyster; Philip Kuriakose; Annette von Drygalski; Joan Cox Gill; Allison Wheeler; Peter Kouides; Miguel A Escobar; Cindy Leissinger; Sarah Galdzicka; Marshall Corson; Crystal Watson; Barbara A Konkle
Journal:  Blood Adv       Date:  2018-06-12

Review 2.  Current Therapeutic Approach to Atrial Fibrillation in Patients with Congenital Hemophilia.

Authors:  Minerva Codruta Badescu; Oana Viola Badulescu; Lacramioara Ionela Butnariu; Mariana Floria; Manuela Ciocoiu; Irina-Iuliana Costache; Diana Popescu; Ioana Bratoiu; Oana Nicoleta Buliga-Finis; Ciprian Rezus
Journal:  J Pers Med       Date:  2022-03-23

3.  Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001-2018.

Authors:  Shermarke Hassan; Rory C Monahan; Evelien P Mauser-Bunschoten; Lize F D van Vulpen; Jeroen Eikenboom; Erik A M Beckers; Louise Hooimeijer; Paula F Ypma; Laurens Nieuwenhuizen; Michiel Coppens; Saskia E M Schols; Frank W G Leebeek; Cees Smit; Mariëtte H Driessens; Saskia le Cessie; Erna C van Balen; Frits R Rosendaal; Johanna G van der Bom; Samantha C Gouw
Journal:  J Thromb Haemost       Date:  2020-12-18       Impact factor: 5.824

4.  Severe bleeding in a patient with factor XIII deficiency and COVID-19.

Authors:  Gabriele Quintavalle; Antonio Coppola; Alessandro Ruggieri; Gianna Franca Rivolta; Elisa Fronti; Francesco Giangregorio; Emanuele Michieletti; Annarita Tagliaferri
Journal:  Haemophilia       Date:  2020-06-24       Impact factor: 4.263

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.